Skip to main content

CannaShark Consulting, LLC

Peptide Industry Consulting

Business Consulting for Peptide Companies in a Shifting Regulatory Market

CannaShark advises compounding pharmacies, clinics, manufacturers and suppliers in the peptide category on how to set up, operate and scale a business whose rules are still being written, with the documentation, controls and economics to hold up when they are.

In short: peptide companies fail far more often on operations than on science. Unclear roles, undocumented processes, vendors nobody qualified, claims nobody reviewed and margins nobody can explain. CannaShark diagnoses those constraints and converts the findings into a prioritized plan, coordinating with your regulatory counsel and quality professionals rather than replacing them.

Why peptide operators are seeking operational counsel now

The U.S. peptide market has moved from the fringe to the center of regulatory attention. In April 2026 the FDA removed twelve peptides from Category 2 of its Section 503A bulk drug substances list, and in July 2026 the Pharmacy Compounding Advisory Committee recommended six of seven reviewed peptides for inclusion on the 503A bulks list. None of those substances is on the list yet; that requires formal rulemaking, and until it happens compounding them remains an area of regulatory risk. Meanwhile “research use only” sales continue online, state boards are paying attention, and payment processors, banks and insurers are asking harder questions.

That combination, high demand, unsettled rules and rising scrutiny, is the environment CannaShark has operated in since 2017. Our work across cannabis, plant-alkaloid manufacturing and other regulated categories rests on one premise: a business in a moving regulatory market needs operating discipline before it needs a bigger marketing budget.

Where CannaShark adds value for peptide businesses

Business setup and operating model

Structure questions to raise with counsel, the operating model that fits your lawful route to market, roles and accountability, and the capital plan to reach a stable month. Peptide business setup.

Compliance operations

Turning regulatory requirements into SOPs, records, training and review routines that staff follow; vendor and raw-material qualification; labeling and claims review workflows; audit and inspection readiness. Peptide compliance operations.

Financial and operational improvement

Unit economics by product and channel, pricing and mix, labor and throughput, purchasing, inventory and cold-chain controls, working capital and the reporting leadership needs to run the business.

Product development and market entry

Go/no-go assessments for new products or channels, sourcing and manufacturing partner evaluation, launch sequencing and the documentation a product needs before it ships. See Product Design & Development.

Systems, AI and executive dashboards

CRM, order management, quality records and reporting connected so owners see the business without living inside it. See AI for Business Operations.

Disputes and expert support

When a supplier, partner, insurer or regulator relationship becomes a dispute, operational and financial analysis grounded in how these businesses actually run. See Expert Witness Services.

Who this is for

  • 503A compounding pharmacies and 503B outsourcing facilities evaluating or operating peptide lines
  • Telehealth, longevity, regenerative and wellness clinics building a compliant prescribing and fulfillment operation
  • Peptide manufacturers, contract manufacturers and packagers scaling production and quality systems
  • Raw-material and research-grade suppliers formalizing controls, documentation and customer qualification
  • Investors and founders deciding whether, when and how to enter the category

How the engagement works

1. Business Evaluation Call

A focused conversation about the business, its lawful route to market and what has already been tried. The purpose is to establish fit.

2. Business Performance Diagnostic™

A structured review of strategy, economics, workflows, roles, systems, controls and management routines. How the Diagnostic works.

3. 90-Day Roadmap

Findings converted into a sequenced plan: what to fix first, who owns it, what it costs and how leadership will know it worked.

4. Execution support

Where useful, CannaShark stays engaged to build the SOPs, systems, dashboards and vendor processes the Roadmap calls for.

A note on what we do not do

CannaShark does not formulate, manufacture or sell peptides, does not provide medical, pharmacy or legal advice and does not help companies market unapproved substances for human use outside a lawful channel. We help lawful operators run well and help prospective operators decide responsibly.

Bring us the decision you need to make

Request a Business Evaluation Call to discuss your peptide business and determine whether the paid Diagnostic is the right next step.

Request a Business Evaluation Call

Frequently asked questions

Does CannaShark provide FDA or legal advice for peptide companies?

No. CannaShark provides business, operations and compliance-operations consulting. We work alongside your regulatory counsel, pharmacist-in-charge or quality lead, and we build the operating systems that let their guidance actually get followed day to day.

Which peptide business models does CannaShark work with?

Compounding pharmacies and the clinics they serve, telehealth and wellness practices, peptide manufacturers and contract manufacturers, raw-material and research-grade suppliers, and brands preparing to enter the category once a lawful route is clear.

Can CannaShark help a company decide whether to enter the peptide market?

Yes. The Business Performance Diagnostic™ can be scoped as a market-entry assessment: the operating model options, the regulatory exposure of each, the capital and systems required and a sequenced 90-day plan if leadership decides to proceed.

Is CannaShark a cannabis-only firm?

No. CannaShark advises complex and regulated businesses broadly. Cannabis is our leading industry specialty, and the operating discipline it demands, from licensing through manufacturing and retail, translates directly to the peptide category.

Related reading

Business Operations Consultant · Why SOPs Fail · Operational Due Diligence Checklist · How to Identify Business Bottlenecks

CannaShark provides business and operations consulting. Engagements do not replace legal, regulatory, medical, pharmacy, tax, accounting or investment advice. Regulatory references reflect public FDA actions as of October 2026 and may change.